News

OHSU’s HIV vaccine technology acquired by Bay Area biotech

January 25, 2017/

A San Francisco-based biotech company has acquired vaccine research by Oregon Health & Science University scientists, marking a critical step toward commercialization of a promising HIV vaccine.

OHSU will become a shareholder in Vir. The university will also get royalties and other payments for products based on OHSU’s technology.

By Lynne Terry | The Oregonian/OregonLive

Full Story: http://www.oregonlive.com/health/index.ssf/2017/01/ohsus_hiv_vaccine_technology_a.html#incart_river_home

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


Working to create a clean and balanced energy portfolio that will provide for a safe and reliable energy future. Learn more at http://www.NorthWesternEnergy.com/BrightFuture

MATR Supporters (view all)


We will bring the North Coast Hiawatha train route back to Southern Montana

Prospera's mission is to advance and inspire diverse economies and communities in southwest Montana.

Make Your Future in the College of Business